{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:11:05Z","timestamp":1790759465854,"version":"4.1.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R01 HL128239"],"award-info":[{"award-number":["R01 HL128239"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01 CA242020"],"award-info":[{"award-number":["R01 CA242020"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["R01 CA251138"],"award-info":[{"award-number":["R01 CA251138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008884","name":"Edward P. Evans Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013730","name":"Henry and Marilyn Taub Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.molmed.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T08:11:59Z","timestamp":1620893519000},"page":"643-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Ettaib","family":"El Marabti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2021.04.005_bb0005","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/272581a0","article-title":"Genes in pieces: were they ever together?","volume":"272","author":"Doolittle","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrm1645","article-title":"Understanding alternative splicing: towards a cellular code","volume":"6","author":"Matlin","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2006.06.023","article-title":"Alternative splicing: new insights from global analyses","volume":"126","author":"Blencowe","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1074\/jbc.R700033200","article-title":"Genome-wide analysis of alternative pre-mRNA splicing","volume":"283","author":"Ben-Dov","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0025","doi-asserted-by":"crossref","first-page":"a003707","DOI":"10.1101\/cshperspect.a003707","article-title":"Spliceosome structure and function","volume":"3","author":"Will","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1261\/rna.876308","article-title":"Splicing regulation: from a parts list of regulatory elements to an integrated splicing code","volume":"14","author":"Wang","year":"2008","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2021.04.005_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/MCB.19.1.261","article-title":"Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA","volume":"19","author":"Schaal","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.1073774","article-title":"Predictive identification of exonic splicing enhancers in human genes","volume":"297","author":"Fairbrother","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.04.005_bb0045","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/nar\/gky056","article-title":"The mechanisms of a mammalian splicing enhancer","volume":"46","author":"Jobbins","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0050","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00018-005-5030-6","article-title":"Silencers regulate both constitutive and alternative splicing events in mammals","volume":"62","author":"Pozzoli","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.molmed.2021.04.005_bb0055","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molcel.2006.05.018","article-title":"General and specific functions of exonic splicing silencers in splicing control","volume":"23","author":"Wang","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-11-reviews0008","article-title":"Finding signals that regulate alternative splicing in the post-genomic era","volume":"3","author":"Ladd","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0065","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/MCB.24.5.1855-1869.2004","article-title":"An intronic enhancer regulates splicing of the twintron of Drosophila melanogaster prospero pre-mRNA by two different spliceosomes","volume":"24","author":"Scamborova","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0070","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/nsmb.2377","article-title":"Intronic splicing enhancers, cognate splicing factors and context-dependent regulation rules","volume":"19","author":"Wang","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF02254432","article-title":"Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression","volume":"11","author":"Zheng","year":"2004","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.molmed.2021.04.005_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wrna.100","article-title":"Evolution of SR protein and hnRNP splicing regulatory factors","volume":"3","author":"Busch","year":"2012","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.molmed.2021.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1017\/S1355838200000960","article-title":"Sorting out the complexity of SR protein functions","volume":"6","author":"Graveley","year":"2000","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2021.04.005_bb0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/gb-2009-10-10-242","article-title":"The SR protein family","volume":"10","author":"Shepard","year":"2009","journal-title":"Genome Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cell.2008.03.010","article-title":"SnapShot: the splicing regulatory machinery","volume":"133","author":"Gabut","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrg.2015.3","article-title":"RNA mis-splicing in disease","volume":"17","author":"Scotti","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcdb.2017.09.036","article-title":"Minor spliceosome and disease","volume":"79","author":"Verma","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0110","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1073\/pnas.0903103106","article-title":"Potential etiologic and functional implications of genome-wide association loci for human diseases and traits","volume":"106","author":"Hindorff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.005_bb0115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/humu.20400","article-title":"Single base-pair substitutions in exon\u2013intron junctions of human genes: nature, distribution, and consequences for mRNA splicing","volume":"28","author":"Krawczak","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2021.04.005_bb0120","doi-asserted-by":"crossref","first-page":"11093","DOI":"10.1073\/pnas.1101135108","article-title":"Using positional distribution to identify splicing elements and predict pre-mRNA processing defects in human genes","volume":"108","author":"Lim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.005_bb0125","doi-asserted-by":"crossref","first-page":"27700","DOI":"10.1074\/jbc.M115.684035","article-title":"The silent sway of splicing by synonymous substitutions","volume":"290","author":"Mueller","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nm.4165","article-title":"Therapeutic targeting of splicing in cancer","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0135","doi-asserted-by":"crossref","DOI":"10.1242\/dev.166322","article-title":"Minor spliceosome inactivation causes microcephaly, owing to cell cycle defects and death of self-amplifying radial glial cells","volume":"145","author":"Baumgartner","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.molmed.2021.04.005_bb0140","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3389\/fgene.2020.00731","article-title":"Innovative therapeutic and delivery approaches using nanotechnology to correct splicing defects underlying disease","volume":"11","author":"Sune-Pou","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0145","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-4939-1221-6_9","article-title":"Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects","volume":"825","author":"Rigo","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/oli.2008.0161","article-title":"Therapeutic potential of splice-switching oligonucleotides","volume":"19","author":"Bauman","year":"2009","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.molmed.2021.04.005_bb0160","first-page":"116","article-title":"Progress toward therapy with antisense-mediated splicing modulation","volume":"11","author":"Du","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.molmed.2021.04.005_bb0165","doi-asserted-by":"crossref","first-page":"9836","DOI":"10.1093\/nar\/gks710","article-title":"Targeting a pre-mRNA structure with bipartite antisense molecules modulates tau alternative splicing","volume":"40","author":"Peacey","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0170","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nchembio.939","article-title":"Synthetic oligonucleotides recruit ILF2\/3 to RNA transcripts to modulate splicing","volume":"8","author":"Rigo","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0175","doi-asserted-by":"crossref","first-page":"50031","DOI":"10.1074\/jbc.M308897200","article-title":"Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides","volume":"278","author":"Villemaire","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4161\/bbug.2.3.15165","article-title":"Modulation of RNA splicing as a potential treatment for cancer","volume":"2","author":"Bauman","year":"2011","journal-title":"Bioeng. Bugs"},{"key":"10.1016\/j.molmed.2021.04.005_bb0185","doi-asserted-by":"crossref","first-page":"8348","DOI":"10.1093\/nar\/gkq731","article-title":"Anti-tumor activity of splice-switching oligonucleotides","volume":"38","author":"Bauman","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0190","doi-asserted-by":"crossref","first-page":"17779","DOI":"10.1073\/pnas.1108482108","article-title":"Antitumorigenic potential of STAT3 alternative splicing modulation","volume":"108","author":"Zammarchi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.005_bb0195","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/nar\/gkaa007","article-title":"AON-induced splice-switching and DMPK pre-mRNA degradation as potential therapeutic approaches for myotonic dystrophy type 1","volume":"48","author":"Stepniak-Konieczna","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0200","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1038\/emboj.2011.259","article-title":"Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas","volume":"30","author":"Lefave","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2021.04.005_bb0205","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1093\/nar\/gku184","article-title":"Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides","volume":"42","author":"Ward","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0210","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1073\/pnas.0633863100","article-title":"Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts","volume":"100","author":"Skordis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.005_bb0215","first-page":"551","article-title":"Two families of benign sex-linked recessive muscular dystrophy","volume":"21","author":"Becker","year":"1962","journal-title":"Rev. Can. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0220","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF00343141","article-title":"A new x-chromosomal muscular dystrophy","volume":"193","author":"Becker","year":"1955","journal-title":"Arch. Psychiatr. Nervenkr. Z. Gesamte Neurol. Psychiatr."},{"key":"10.1016\/j.molmed.2021.04.005_bb0225","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","article-title":"Dystrophin and mutations: one gene, several proteins, multiple phenotypes","volume":"2","author":"Muntoni","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0230","doi-asserted-by":"crossref","first-page":"31957","DOI":"10.1074\/jbc.M203478200","article-title":"Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex","volume":"277","author":"Baccon","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0235","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0092-8674(00)80368-2","article-title":"The SMN\u2013SIP1 complex has an essential role in spliceosomal snRNP biogenesis","volume":"90","author":"Fischer","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0240","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ncb1101-945","article-title":"A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs","volume":"3","author":"Meister","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0245","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","article-title":"Dystrophin-deficient cardiomyopathy","volume":"67","author":"Kamdar","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0250","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mus.23810","article-title":"Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophy","volume":"48","author":"Mendell","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.molmed.2021.04.005_bb0255","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.molmed.2021.04.005_bb0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0022-510X(91)90039-A","article-title":"Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy","volume":"101","author":"Arahata","year":"1991","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molmed.2021.04.005_bb0265","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI117693","article-title":"Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe","volume":"95","author":"Takeshima","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2021.04.005_bb0270","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/hmg\/7.7.1083","article-title":"Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides","volume":"7","author":"Dunckley","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0275","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/10.15.1547","article-title":"Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells","volume":"10","author":"van Deutekom","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm1345","article-title":"Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology","volume":"12","author":"Alter","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0285","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/mt.2010.72","article-title":"Preclinical PK and PD studies on 2\u2032-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model","volume":"18","author":"Heemskerk","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molmed.2021.04.005_bb0290","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.38","article-title":"Long-term exon skipping studies With 2\u2032-O-methyl phosphorothioate antisense oligonucleotides in dystrophic mouse models","volume":"1","author":"Tanganyika-de Winter","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.molmed.2021.04.005_bb0295","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21627","article-title":"Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs","volume":"65","author":"Yokota","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0300","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2147\/DDDT.S97635","article-title":"Eteplirsen in the treatment of Duchenne muscular dystrophy","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.molmed.2021.04.005_bb0305","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418776932","article-title":"Antisense oligonucleotides in neurological disorders","volume":"11","author":"Wurster","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.molmed.2021.04.005_bb0310","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2015.05.008","article-title":"Exon skipping therapy for Duchenne muscular dystrophy","volume":"87","author":"Kole","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molmed.2021.04.005_bb0315","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0713","article-title":"Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy","volume":"10","author":"Komaki","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0320","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40265-020-01267-2","article-title":"Golodirsen: first approval","volume":"80","author":"Heo","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.molmed.2021.04.005_bb0325","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/archneurol.2011.74","article-title":"Spinal muscular atrophy: a timely review","volume":"68","author":"Kolb","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0330","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0335","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tcb.2004.03.010","article-title":"Why do cells need an assembly machine for RNA\u2013protein complexes?","volume":"14","author":"Yong","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0340","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2","volume":"4","author":"Mailman","year":"2002","journal-title":"Genet. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0345","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.a.30251","article-title":"Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2","volume":"130A","author":"Prior","year":"2004","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.molmed.2021.04.005_bb0350","doi-asserted-by":"crossref","first-page":"45476","DOI":"10.1074\/jbc.M107632200","article-title":"Modulation of survival motor neuron pre-mRNA splicing by inhibition of alternative 3\u2019 splice site pairing","volume":"276","author":"Lim","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0355","doi-asserted-by":"crossref","first-page":"23271","DOI":"10.1074\/jbc.M200851200","article-title":"Identification of a cis-acting element for the regulation of SMN exon 7 splicing","volume":"277","author":"Miyajima","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0360","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1128\/MCB.26.4.1333-1346.2006","article-title":"Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron","volume":"26","author":"Singh","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0365","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/hmg\/ddp076","article-title":"Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy","volume":"18","author":"Baughan","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0370","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/hmg\/ddi078","article-title":"SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN","volume":"14","author":"Le","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0375","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","article-title":"Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice","volume":"82","author":"Hua","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0380","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1101\/gad.1941310","article-title":"Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model","volume":"24","author":"Hua","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2021.04.005_bb0385","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001777","article-title":"Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy","volume":"3","author":"Passini","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0390","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/gt.2017.34","article-title":"How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy","volume":"24","author":"Singh","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.molmed.2021.04.005_bb0395","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.04.005_bb0400","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/hmg\/ddv629","article-title":"Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset","volume":"25","author":"Feng","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0405","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","article-title":"Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)","volume":"61","author":"Ratni","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0410","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41467-017-01559-4","article-title":"Binding to SMN2 pre-mRNA\u2013protein complex elicits specificity for small molecule splicing modifiers","volume":"8","author":"Sivaramakrishnan","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.04.005_bb0415","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/bcp.13786","article-title":"A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier","volume":"85","author":"Sturm","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0420","doi-asserted-by":"crossref","first-page":"17472","DOI":"10.1038\/s41598-020-74346-9","article-title":"Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy","volume":"10","author":"Ando","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.04.005_bb0425","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nchembio.1837","article-title":"SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice","volume":"11","author":"Palacino","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0430","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molmed.2021.04.005_bb0435","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng.1031","article-title":"Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes","volume":"44","author":"Graubert","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0440","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0445","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0450","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cell.2019.12.011","article-title":"SnapShot: splicing alterations in cancer","volume":"180","author":"Rahman","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0455","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0460","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0465","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0470","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0475","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0480","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-019-1650-0","article-title":"Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma","volume":"574","author":"Suzuki","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0485","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41586-019-1651-z","article-title":"The U1 spliceosomal RNA is recurrently mutated in multiple cancers","volume":"574","author":"Shuai","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0490","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molcel.2017.12.029","article-title":"The augmented R-loop is a unifying mechanism for myelodysplastic syndromes induced by high-risk splicing factor mutations","volume":"69","author":"Chen","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0495","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41586-019-1646-9","article-title":"Spliceosomal disruption of the non-canonical BAF complex in cancer","volume":"574","author":"Inoue","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0500","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.gde.2017.10.010","article-title":"Targeting splicing abnormalities in cancer","volume":"48","author":"Agrawal","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.molmed.2021.04.005_bb0505","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1158\/1078-0432.CCR-13-0485","article-title":"Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors","volume":"19","author":"Eskens","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0510","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10637-013-0046-5","article-title":"A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors","volume":"32","author":"Hong","year":"2014","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.molmed.2021.04.005_bb0515","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.stem.2016.08.003","article-title":"RNA splicing modulation selectively impairs leukemia stem cell maintenance in secondary human AML","volume":"19","author":"Crews","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0520","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nm.4493","article-title":"H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers","volume":"24","author":"Seiler","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0525","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.04.005_bb0530","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nchembio.2363","article-title":"Selective degradation of splicing factor CAPERalpha by anticancer sulfonamides","volume":"13","author":"Uehara","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0535","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2019.07.003","article-title":"Therapeutic targeting of RNA splicing catalysis through inhibition of protein arginine methylation","volume":"36","author":"Fong","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0540","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41594-019-0313-z","article-title":"PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia","volume":"26","author":"Radzisheuskaya","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0545","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0955-0674(00)00211-8","article-title":"Spliceosomal UsnRNP biogenesis, structure and function","volume":"13","author":"Will","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0550","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wrna.1141","article-title":"The significant other: splicing by the minor spliceosome","volume":"4","author":"Turunen","year":"2013","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.molmed.2021.04.005_bb0555","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/emboj.2011.367","article-title":"A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well","volume":"31","author":"Daubner","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2021.04.005_bb0560","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nsb0397-215","article-title":"Crystal structure of the two RNA binding domains of human hnRNP A1 at 1.75 \u00c5 resolution","volume":"4","author":"Shamoo","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0565","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(00)80016-7","article-title":"Terminal intron dinucleotide sequences do not distinguish between U2- and U12-dependent introns","volume":"1","author":"Dietrich","year":"1997","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0570","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/emmm.201303573","article-title":"Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiency","volume":"6","author":"Argente","year":"2014","journal-title":"Embo Mol. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0575","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1202205","article-title":"Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA","volume":"332","author":"Edery","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.04.005_bb0580","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1200587","article-title":"Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I","volume":"332","author":"He","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.molmed.2021.04.005_bb0585","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1038\/ncomms9718","article-title":"Compound heterozygous mutations in the noncoding RNU4ATAC cause Roifman syndrome by disrupting minor intron splicing","volume":"6","author":"Merico","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.04.005_bb0590","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1261\/rna.071423.119","article-title":"New insights into minor splicing \u2013 a transcriptomic analysis of cells derived from TALS patients","volume":"25","author":"Cologne","year":"2019","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2021.04.005_bb0595","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ajmg.a.38581","article-title":"The expanding phenotype of RNU4ATAC pathogenic variants to Lowry Wood syndrome","volume":"176","author":"Farach","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.molmed.2021.04.005_bb0600","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nsmb873","article-title":"An LKB1 AT\u2013AC intron mutation causes Peutz\u2013Jeghers syndrome via splicing at noncanonical cryptic splice sites","volume":"12","author":"Hastings","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0605","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1399-0004.2003.00132.x","article-title":"Identification of three novel SEDL mutations, including mutation in the rare, non-canonical splice site of exon 4","volume":"64","author":"Shaw","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0610","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1093\/hmg\/ddt262","article-title":"Decreased number of gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis","volume":"22","author":"Ishihara","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0615","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.15252\/embj.201593791","article-title":"Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants","volume":"35","author":"Reber","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.molmed.2021.04.005_bb0620","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1038\/ncomms7171","article-title":"ALS-causative mutations in FUS\/TLS confer gain and loss of function by altered association with SMN and U1-snRNP","volume":"6","author":"Sun","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2021.04.005_bb0625","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcdb.2014.04.026","article-title":"SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease","volume":"32","author":"Li","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0630","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cell.2008.03.031","article-title":"SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing","volume":"133","author":"Zhang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0635","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/hmg\/ddl015","article-title":"An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements","volume":"15","author":"Disset","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0640","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature10456","article-title":"Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy","volume":"478","author":"Taniguchi-Ikeda","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0645","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awq051","article-title":"PINK1-linked parkinsonism is associated with Lewy body pathology","volume":"133","author":"Samaranch","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.molmed.2021.04.005_bb0650","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-013-1219-1","article-title":"The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons","volume":"127","author":"Iovino","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0655","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.autneu.2012.10.012","article-title":"Familial dysautonomia (Riley\u2013Day syndrome): when baroreceptor feedback fails","volume":"172","author":"Norcliffe-Kaufmann","year":"2012","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.molmed.2021.04.005_bb0660","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1540-8167.2004.40096.x","article-title":"Electrophysiological and histopathological characteristics of progressive atrioventricular block accompanied by familial dilated cardiomyopathy caused by a novel mutation of lamin A\/C gene","volume":"16","author":"Otomo","year":"2005","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0665","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.2693","article-title":"RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing","volume":"18","author":"Guo","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2021.04.005_bb0670","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0675","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/hmg\/9.9.1453","article-title":"Identification of mutations in the gene encoding lamins A\/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)","volume":"9","author":"Muchir","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0680","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/jc.2005-2746","article-title":"A LMNA splicing mutation in two sisters with severe Dunnigan-type familial partial lipodystrophy type 2","volume":"91","author":"Morel","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2021.04.005_bb0685","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/hmg\/ddm124","article-title":"A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol","volume":"16","author":"Zhu","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0690","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/0004563215572702","article-title":"LDLR gene synonymous mutation c.1813C>T results in mRNA splicing variation in a kindred with familial hypercholesterolaemia","volume":"52","author":"Ho","year":"2015","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.molmed.2021.04.005_bb0695","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/hmg\/ddr094","article-title":"PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa","volume":"20","author":"Tanackovic","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0700","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1093\/hmg\/ddu127","article-title":"A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G)","volume":"23","author":"Vieira","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0705","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1093\/hmg\/ddx225","article-title":"Messenger RNA processing is altered in autosomal dominant leukodystrophy","volume":"26","author":"Bartoletti-Stella","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0710","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1086\/511992","article-title":"Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer","volume":"80","author":"Nielsen","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0715","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2014.04.011","article-title":"Myotonic dystrophy","volume":"32","author":"Thornton","year":"2014","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.molmed.2021.04.005_bb0720","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddg215","article-title":"Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene","volume":"12","author":"Aznarez","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0725","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.2010.086751","article-title":"Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa","volume":"48","author":"Kiritsi","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0730","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1073\/pnas.121027598","article-title":"Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI","volume":"98","author":"Camacho Vanegas","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.005_bb0735","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ng1297-467","article-title":"Donor splice-site mutations in WT1 are responsible for Frasier syndrome","volume":"17","author":"Barbaux","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0740","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0092-8674(81)90412-8","article-title":"Beta+ thalassemia: aberrant splicing results from a single point mutation in an intron","volume":"27","author":"Busslinger","year":"1981","journal-title":"Cell"},{"key":"10.1016\/j.molmed.2021.04.005_bb0745","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/302591a0","article-title":"Specific transcription and RNA splicing defects in five cloned beta-thalassaemia genes","volume":"302","author":"Treisman","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2021.04.005_bb0750","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/humu.22266","article-title":"An overview and update of ATP7A mutations leading to Menkes disease and occipital horn syndrome","volume":"34","author":"Tumer","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2021.04.005_bb0755","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1038\/s41598-018-25204-2","article-title":"Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation","volume":"8","author":"Yanaizu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2021.04.005_bb0760","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/hep.27620","article-title":"Analysis of aberrant pre-messenger RNA splicing resulting from mutations in ATP8B1 and efficient in vitro rescue by adapted U1 small nuclear RNA","volume":"61","author":"van der Woerd","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2021.04.005_bb0765","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1399-0004.2008.01040.x","article-title":"Molecular characterization of Portuguese patients with mucopolysaccharidosis IIIC: two novel mutations in the HGSNAT gene","volume":"74","author":"Coutinho","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0770","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.005_bb0775","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/nar\/19.5.1172","article-title":"Splice junction mutations in factor IX gene resulting in severe hemophilia B","volume":"19","author":"Chen","year":"1991","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2021.04.005_bb0780","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1538-7836.2005.01140.x","article-title":"Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene","volume":"3","author":"El-Maarri","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.molmed.2021.04.005_bb0785","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/507318","article-title":"Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis","volume":"79","author":"den Hollander","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0790","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/hmg\/ddn057","article-title":"Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect","volume":"17","author":"Olsson","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0795","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00218833","article-title":"Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype\u2013phenotype relationship","volume":"97","author":"Ploos van Amstel","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0800","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bone.2016.10.022","article-title":"A homozygous intronic branch-point deletion in the ALPL gene causes infantile hypophosphatasia","volume":"94","author":"Mentrup","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.molmed.2021.04.005_bb0805","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbiotec.2020.03.012","article-title":"Pre-mRNA splicing defects and RNA binding protein involvement in Niemann Pick type C disease","volume":"318","author":"Paron","year":"2020","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0810","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/humu.22705","article-title":"Identification and characterization of aberrant GAA pre-mRNA splicing in pompe disease using a generic approach","volume":"36","author":"Bergsma","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.molmed.2021.04.005_bb0815","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1101\/sqb.2006.71.024","article-title":"Regulation of alternative splicing by snoRNAs","volume":"71","author":"Kishore","year":"2006","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.molmed.2021.04.005_bb0820","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00439-005-0025-9","article-title":"Splicing mutation associated with Rett syndrome and an experimental approach for genetic diagnosis","volume":"118","author":"Abuhatzira","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0825","doi-asserted-by":"crossref","first-page":"E5363","DOI":"10.1073\/pnas.1722546115","article-title":"Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome","volume":"115","author":"Osenberg","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2021.04.005_bb0830","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00439-008-0543-3","article-title":"Gene structure and mutant alleles of PCDH15: nonsyndromic deafness DFNB23 and type 1 Usher syndrome","volume":"124","author":"Ahmed","year":"2008","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2021.04.005_bb0835","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11882-014-0510-0","article-title":"Splice-correction strategies for treatment of X-linked agammaglobulinemia","volume":"15","author":"Bestas","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.molmed.2021.04.005_bb0840","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.str.2012.08.024","article-title":"The survival motor neuron protein forms soluble glycine zipper oligomers","volume":"20","author":"Martin","year":"2012","journal-title":"Structure"},{"key":"10.1016\/j.molmed.2021.04.005_bb0845","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/s41467-020-19514-1","article-title":"Identification of phenothiazine derivatives as UHM-binding inhibitors of early spliceosome assembly","volume":"11","author":"Jagtap","year":"2020","journal-title":"Nat. Commun."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491421001003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491421001003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:23:47Z","timestamp":1761463427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491421001003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":169,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1471491421001003"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2021.04.005","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}